Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Obstructive Lung Diseases

Free Subscription Articles published in Arch Bronconeumol Retrieve available abstracts of 106 articles: HTML format

Single Articles

May 2026
1. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Valverde-Molina J
   News From the Severe Asthma Consensus 2025 Review.
   Arch Bronconeumol. 2026;62:291-293.
   PubMed    
   
   
   
2. DE MIGUEL-DIEZ J, Suarez-Llanos JP, Figueira-Goncalves JM, Breton-Lesmes I, et al
   SEPAR and SEEN Consensus Document on Nutritional Assessment and Management in Patients with COPD.
   Arch Bronconeumol. 2026;62:325-338.
   PubMed     Abstract available
   
   
   
3. PLAZA V, Stok AM, Alvarez-Gutierrez F, Ballini L, et al
   Evaluation of the SEPAR-ALAT Asthma Exacerbation Severity Classification.
   Arch Bronconeumol. 2026 May 1:S0300-2896(26)00167.
   PubMed    
   
   
   April 2026
4. TIOTIU A, Guidos Fogelbach G, Chong-Neto HJ, Novakova P, et al
   Impact of Biologics Administered for Severe Asthma on T2-comorbidities: A Narrative Review.
   Arch Bronconeumol. 2026 Apr 24:S0300-2896(26)00150.
   PubMed     Abstract available
   
   
   
5. PEDRO-TUDELA A, Garcia-Ortega A, Martinez-Moragon E
   Pasteurella canis Pneumonia in a Severe Asthmatic Receiving Biologic Therapy: A Zoonotic Complication of Pet-related Anthropomorphism.
   Arch Bronconeumol. 2026 Apr 24:S0300-2896(26)00156.
   PubMed    
   
   
   
6. SORIANO JB, Lopez-Campos JL
   The World's Burden of Chronic Respiratory Disease: An Epidemiological Review of Asthma, COPD, Interstitial Lung Disease, and Smoking in the 21st Century.
   Arch Bronconeumol. 2026 Apr 23:S0300-2896(26)00151.
   PubMed     Abstract available
   
   
   
7. GALERA R, Casitas R, Gavilan A, Redondo S, et al
   Which FEV(1) Decline Index Best Predicts Mortality in COPD? A 15-year Cohort Study.
   Arch Bronconeumol. 2026;62:217-225.
   PubMed     Abstract available
   
   
   March 2026
8. LI B, Ji X, Xiang Z, Zhao F, et al
   CD126(+) Central Memory CD8(+) T Cells Are Enriched in the Airway in Asthma and Associated With Disease Severity.
   Arch Bronconeumol. 2026 Mar 22:S0300-2896(26)00107.
   PubMed    
   
   
   February 2026
9. CASTELLANOS LOPEZ L, Mira Palomino C, Raboso Moreno B
   Successful Management of Chronic Achromobacter xylosoxidans Bronchial Infection With Nebulized Levofloxacin in a Patient With Non-cystic Fibrosis Bronchiectasis.
   Arch Bronconeumol. 2026 Feb 16:S0300-2896(26)00078.
   PubMed    
   
   
   
10. HALPIN DMG, Masekela R, Vogelmeier CF, Ozoh OB, et al
    Addressing the Global Challenges of COPD and Asthma: A Shared Vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA).
    Arch Bronconeumol. 2026;62:113-117.
    PubMed     Abstract available
    
    
    
11. ROFFEL MP, Brandsma CA, Faiz A, Jonker MR, et al
    The Role of miR-320d in Regulation of Cigarette Smoke-Induced Pro-Inflammatory Responses in COPD.
    Arch Bronconeumol. 2026;62:86-93.
    PubMed     Abstract available
    
    
    January 2026
12. TRAMONTANO A, Caporaso M, Macciocchi G, Simonetta E, et al
    New Perspectives in the Treatment of Bronchiectasis.
    Arch Bronconeumol. 2026 Jan 9:S0300-2896(26)00004.
    PubMed     Abstract available
    
    
    
13. GOROSPE L, Chamorro-Perez J, Mirambeaux-Villalona RM
    Emphysematous Subcarinal Lymphadenitis Complicated With Pleural Empyema: Successful Management With Antibiotic Therapy and Percutaneous Drainage.
    Arch Bronconeumol. 2026 Jan 8:S0300-2896(26)00002.
    PubMed    
    
    
    
14. SOLER-CATALUNA JJ, Villagrasa M, Catalan P, Alcazar-Navarrete B, et al
    Risk validation of a new quantitative score for clinical control of chronic obstructive pulmonary disease: The RADAR score.
    Arch Bronconeumol. 2026;62:28-34.
    PubMed     Abstract available
    
    
    
15. CASANOVA C, Gonzalez-Davila E, de Torres JP, Cabrera C, et al
    Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD.
    Arch Bronconeumol. 2026;62:20-27.
    PubMed     Abstract available
    
    
    
16. DENG Z, Wu F, Wan Q, Dai C, et al
    Impaired Ventilatory Efficiency Identifies High-Risk Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2026;62:10-19.
    PubMed     Abstract available
    
    
    
17. MORENO-ZABALETA R, Lujan Torne M, Sayas Catalan J, Garcia Torres P, et al
    SEPAR Position Paper on the Use of High Flow Nasal Cannula Therapy in the Home Setting.
    Arch Bronconeumol. 2026;62:35-43.
    PubMed     Abstract available
    
    
    December 2025
18. SEGHERS-CARRERAS C, Jimenez-Gomez M, Diaz-Campos RM
    Severe Asthma Unresponsive to Therapy as the Initial Presentation of Pulmonary Venous Drainage Obstruction.
    Arch Bronconeumol. 2025 Dec 23:S0300-2896(25)00438.
    PubMed    
    
    
    
19. DIAZ-CAMPOS R, Jimenez-Gomez M, Cisneros-Serrano C, Trisan-Alonso A, et al
    Exhaled Volatile Organic Compounds as Potential Biomarkers of Exacerbation Risk in Asthma.
    Arch Bronconeumol. 2025 Dec 22:S0300-2896(25)00441.
    PubMed    
    
    
    
20. MARTINEZ-GARCIA MA, Aksamit T, Asakura T, Burr L, et al
    The Worldwide Puzzle of Bronchiectasis Etiology in Adults.
    Arch Bronconeumol. 2025 Dec 4:S0300-2896(25)00419.
    PubMed     Abstract available
    
    
    
21. ALMONACID C, Quirce S, Blanco M, Del Cubillo A, et al
    Inside GEMA 5.5: Expert Insights on the Latest Changes in Asthma Management.
    Arch Bronconeumol. 2025 Dec 2:S0300-2896(25)00418.
    PubMed     Abstract available
    
    
    
22. MIRAVITLLES M, Calle M, Molina J, Almagro P, et al
    Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD.
    Arch Bronconeumol. 2025;61:766-782.
    PubMed     Abstract available
    
    
    November 2025
23. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Valverde-Molina J
    News From the Severe Asthma Consensus 2025 Review.
    Arch Bronconeumol. 2025 Nov 14:S0300-2896(25)00409.
    PubMed    
    
    
    
24. ORDONEZ GOMEZ P, Minana MD, Garcia-Ballesteros C, Signes-Costa J, et al
    Immune Gene Polymorphisms and Lung Cancer Risk in Chronic Obstructive Pulmonary Disease with Emphysema.
    Arch Bronconeumol. 2025 Nov 4:S0300-2896(25)00388.
    PubMed    
    
    
    
25. SINGH D, Menendez Lobo A, Higham A, Alcazar Navarrete B, et al
    Biological Therapy in COPD Management: Current Evidence, Challenges and Opportunities.
    Arch Bronconeumol. 2025;61:690-696.
    PubMed     Abstract available
    
    
    October 2025
26. SOLARAT B, Mendoza N, Perea L, Amaro R, et al
    Systemic Immune Dysregulation in Patients With Bronchiectasis and Chronic Pseudomonas aeruginosa Infection.
    Arch Bronconeumol. 2025 Oct 25:S0300-2896(25)00382.
    PubMed    
    
    
    
27. DE-TORRES JP, Wilson DO, Wisnivesky JP, Salvatore MM, et al
    Chronic Respiratory Diseases and Lung Cancer Risk.
    Arch Bronconeumol. 2025 Oct 25:S0300-2896(25)00383.
    PubMed     Abstract available
    
    
    
28. SANZ-FRAILE H, Herrero-Cortina B, Rovira-Ribalta N, Fernandez-Barat L, et al
    From Colour to Mechanics: A Dual Biomarker for Bronchiectasis Sputum.
    Arch Bronconeumol. 2025 Oct 4:S0300-2896(25)00340.
    PubMed    
    
    
    
29. HAMMADI A, Hoyas-Sanchez C, Romero-Linares A, Alvarez-Muro L, et al
    All-Cause and Cardiovascular Mortality With Single Inhaler Triple Therapy Versus Double Therapies for COPD: A Systematic Review and Metanalysis.
    Arch Bronconeumol. 2025;61:594-602.
    PubMed     Abstract available
    
    
    September 2025
30. ADRISH M, Hanania NA
    Inflammation Without Borders: The Interconnected Pathways of Asthma and Heart Disease.
    Arch Bronconeumol. 2025 Sep 22:S0300-2896(25)00338.
    PubMed    
    
    
    
31. MCSHANE PJ
    Are Dipeptidyl Peptidase-1 Inhibitors the Future Anti-inflammatory Treatment in Bronchiectasis?
    Arch Bronconeumol. 2025 Sep 12:S0300-2896(25)00312.
    PubMed    
    
    
    
32. ZHOU Y, Wu F, Li H, Deng Z, et al
    Effect of Carbocysteine on Exacerbations and Lung Function in Patients With Mild-to-Moderate Chronic Obstructive Pulmonary Disease: A Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial.
    Arch Bronconeumol. 2025;61:528-535.
    PubMed     Abstract available
    
    
    
33. PADILLA JM, Alfaro E, Casitas R, Galera R, et al
    Characterization of Inactive COPD Patients: Barriers to Physical Activity and Perceived Impact of Inactivity.
    Arch Bronconeumol. 2025;61:555-563.
    PubMed     Abstract available
    
    
    
34. SAYAS CATALAN J, Lalmolda C, Hernandez-Voth A, Corral Blanco M, et al
    Thoracoabdominal Asynchrony in Very Severe COPD: Clinical and Functional Correlates During Exercise.
    Arch Bronconeumol. 2025;61:544-554.
    PubMed     Abstract available
    
    
    
35. ARTEAGA M, Lopez-Duque L, Laorden D, Torrado I, et al
    Inhaled Corticosteroid Reduction Effects on Asthma Outcomes After Three Years of Benralizumab Treatment in Severe Asthma Patients.
    Arch Bronconeumol. 2025 Sep 1:S0300-2896(25)00299.
    PubMed    
    
    
    August 2025
36. GIMENO-SANTOS E, Vilaro J, Arbilllaga-Etxarri A, Herrero-Cortina B, et al
    Development and Comparison of Reference Equations for the Six-Minute Walk Test in Spanish Healthy Adults Aged 45-85 Years.
    Arch Bronconeumol. 2025;61:459-466.
    PubMed     Abstract available
    
    
    July 2025
37. CHANG Q, Zhu Y, Liang H, Liu B, et al
    Association of Plasma Metabolic Profiling With Asthma Phenotypes and Exacerbation.
    Arch Bronconeumol. 2025 Jul 29:S0300-2896(25)00268.
    PubMed    
    
    
    
38. BETANCOR D, Rial MJ, Olaguibel JM, Del Pozo V, et al
    Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort.
    Arch Bronconeumol. 2025 Jul 5:S0300-2896(25)00230.
    PubMed    
    
    
    June 2025
39. LI XS, Gao YH
    Rethinking Pseudomonas aeruginosa in Bronchiectasis.
    Arch Bronconeumol. 2025 Jun 23:S0300-2896(25)00223.
    PubMed    
    
    
    
40. KING PT
    Childhood Pulmonary Virus Infection and Future Bronchiectasis.
    Arch Bronconeumol. 2025 Jun 7:S0300-2896(25)00213.
    PubMed    
    
    
    
41. LU L, Wan Q, Tang G, Wu F, et al
    New Classifications of COPD Severity Based on Impulse Oscillometry: A SAIO Grade Base on ECOPD Cohort in China.
    Arch Bronconeumol. 2025;61:334-340.
    PubMed     Abstract available
    
    
    May 2025
42. MAC AOGAIN M, Chotirmall SH
    Antimicrobial Resistance and Pathobionts in Bronchiectasis: An Old Problem for a New Era?
    Arch Bronconeumol. 2025 May 16:S0300-2896(25)00183.
    PubMed    
    
    
    
43. VAN DER MOLEN MC, Posthuma R, Vaes AW, Spruit MA, et al
    Metabolic Changes After Bronchoscopic Lung Volume Reduction With Endobronchial Valves in COPD Patients.
    Arch Bronconeumol. 2025;61:282-289.
    PubMed     Abstract available
    
    
    
44. CASAL-GUISANDE M, Represas-Represas C, Golpe R, Fernandez-Garcia A, et al
    Clinical and Social Characterization of Patients Hospitalized for COPD Exacerbation Using Machine Learning Tools.
    Arch Bronconeumol. 2025;61:264-273.
    PubMed     Abstract available
    
    
    
45. GOLPE R, Veiga I, Dacal-Rivas D, Blanco-Cid N, et al
    Blood Eosinophil Count During Severe Bronchiectasis Exacerbation and Risk of Hospital Readmission.
    Arch Bronconeumol. 2025 May 1:S0300-2896(25)00156.
    PubMed    
    
    
    April 2025
46. MAROTO E, Esteban Lombarte MDM, Garriga-Baraut T, Garcia Del Cerro G, et al
    Efficacy of a Digitally Supported Intervention for Children and Adolescents With Difficult-to-control Asthma (INSPIRINGKIDS): Results From a Multicentre Randomized Controlled Trial.
    Arch Bronconeumol. 2025 Apr 28:S0300-2896(25)00140.
    PubMed    
    
    
    
47. DACAL RIVAS D, Martinez-Moragon E, Plaza V, Cisneros Serrano C, et al
    Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study.
    Arch Bronconeumol. 2025 Apr 26:S0300-2896(25)00139.
    PubMed     Abstract available
    
    
    
48. GARCIA-OLIVE I, Radua J, Hernandez Biette A, Bruguera N, et al
    Evaluating the Utility of Biologic Therapies in Patients With Severe Asthma and Comorbid Bronchiectasis: A Systematic Review With Meta-analysis of Retrospective Studies.
    Arch Bronconeumol. 2025 Apr 26:S0300-2896(25)00149.
    PubMed    
    
    
    
49. MUNOZ-SANCHEZ B, Leon-Lloreda A, Romero-Falcon A, Medina-Gallardo JF, et al
    Identification of Fractional Exhaled Nitric Oxide Cutoff Values for the Diagnosis of Asthma.
    Arch Bronconeumol. 2025 Apr 2:S0300-2896(25)00121.
    PubMed    
    
    
    
50. OSCULLO G, Mendez R, Olveira C, Giron R, et al
    Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry.
    Arch Bronconeumol. 2025;61:196-202.
    PubMed     Abstract available
    
    
    March 2025
51. RODRIGUEZ-CHIARADIA DA, Torres-Castro R, Piccari L, Garcia-Ortega A, et al
    A Systematic Review and Expert Recommendation on the Diagnosis of Pulmonary Hypertension Associated With Lung Disease: A Position Paper of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR).
    Arch Bronconeumol. 2025 Mar 28:S0300-2896(25)00112.
    PubMed     Abstract available
    
    
    
52. MARTIN-GONZALEZ E, Perez-Garcia J, Martin-Almeida M, Hernandez-Perez JM, et al
    Genome-wide Association Study of Asthma Exacerbations in the Spanish Population.
    Arch Bronconeumol. 2025 Mar 20:S0300-2896(25)00091.
    PubMed    
    
    
    
53. FERNANDEZ-BARAT L, Lopez-Aladid R, Alcaraz-Serrano V, Vazquez N, et al
    Clinical and Lung Microbiome Impact of Chronic Versus Intermittent Pseudomonas aeruginosa Infection in Bronchiectasis.
    Arch Bronconeumol. 2025 Mar 18:S0300-2896(25)00082.
    PubMed     Abstract available
    
    
    
54. JIN KN, Lee HJ, Park H, Lee JK, et al
    Mucus Plugs as Precursors to Exacerbation and Lung Function Decline in COPD Patients.
    Arch Bronconeumol. 2025;61:138-146.
    PubMed     Abstract available
    
    
    
55. BETANCOR D, Olaguibel JM, Del Pozo V, Alvarez Puebla MJ, et al
    FEV(1)Q as a Predictive Metric for Asthma Outcomes.
    Arch Bronconeumol. 2025 Mar 1:S0300-2896(25)00072.
    PubMed    
    
    
    February 2025
56. OSCULLO G, Bekki A, Olveira C, Giron R, et al
    Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis.
    Arch Bronconeumol. 2025 Feb 4:S0300-2896(25)00043.
    PubMed     Abstract available
    
    
    
57. BERNABEU-MORA R, Valera-Novella E, Bernabeu-Serrano ET, Soler-Cataluna JJ, et al
    Five-Repetition Sit-to-Stand Test as Predictor of Mortality in High Risk COPD Patients.
    Arch Bronconeumol. 2025;61:90-95.
    PubMed     Abstract available
    
    
    January 2025
58. OSCULLO G, Bekki A, Martinez-Garcia MA
    Microbiome, Metabolome and Complexity in Bronchiectasis: The Future is Here.
    Arch Bronconeumol. 2025 Jan 31:S0300-2896(25)00033.
    PubMed    
    
    
    
59. ZHANG XX, He ZF, He JH, Chen ZM, et al
    Sputum Microbiota Correlates With Metabolome and Clinical Outcomes in Asthma-Bronchiectasis Overlap.
    Arch Bronconeumol. 2025 Jan 6:S0300-2896(25)00006.
    PubMed     Abstract available
    
    
    
60. ROMERO FALCON MAA, Leon Lloreda A, Gomez-Bastero A
    Experience With the Use of Biological Therapy for Asthma Control During Pregnancy: Preliminary Results.
    Arch Bronconeumol. 2025 Jan 6:S0300-2896(25)00004.
    PubMed    
    
    
    
61. ERSOZ H, Torres-Duran M, Turner AM, Tanash H, et al
    Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry.
    Arch Bronconeumol. 2025;61:22-30.
    PubMed     Abstract available
    
    
    December 2024
62. CHEN X, Li D, Ma Z
    A Commentary on 'Effect of the Antibody-Mediated Immune Responses on COPD, Asthma, and Lung Function: A Mendelian Randomization Study'.
    Arch Bronconeumol. 2024 Dec 5:S0300-2896(24)00454.
    PubMed    
    
    
    
63. ALVARADO-MIRANDA M, Solano A, Marsico S, Nunez-Robainas A, et al
    Clinical Implications of Functional Imaging in the Assessment of Bronchiectasis-Associated Sarcopenia.
    Arch Bronconeumol. 2024 Dec 4:S0300-2896(24)00453.
    PubMed     Abstract available
    
    
    November 2024
64. ANSEDE-BORDONABA G, Giron-Moreno RM, Martinez-Vergara A
    Ulcerative Colitis, Bronchiectasis and Tofacitinib.
    Arch Bronconeumol. 2024 Nov 22:S0300-2896(24)00438.
    PubMed    
    
    
    
65. DE LUCA GR, Diciotti S, Mascalchi M
    The Pivotal Role of Baseline LDCT for Lung Cancer Screening in the Era of Artificial Intelligence.
    Arch Bronconeumol. 2024 Nov 22:S0300-2896(24)00439.
    PubMed     Abstract available
    
    
    October 2024
66. GUIXING X, Yilin L, Huaying F, Fanrong L, et al
    Effect of the Antibody-mediated Immune Responses on COPD, Asthma, and Lung Function: A Mendelian Randomization Study.
    Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00406.
    PubMed     Abstract available
    
    
    
67. PADILLA-GALO A, Rubio-Moreno M, Valencia-Azcona B
    Asthma-COPD Overlap - A Gateway to Biological Treatment.
    Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00409.
    PubMed    
    
    
    
68. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G
    Reply to Letter: The Importance of Multidisciplinary Teams in the Evaluation of the Remission of Chronic Rhinosinusitis in Severe Asthma.
    Arch Bronconeumol. 2024 Oct 9:S0300-2896(24)00377.
    PubMed    
    
    
    
69. SCHILFARTH P, Maurac A, Macey J, Decloedt C, et al
    Sleep Quality in Patients Receiving Long-term NIV: A Prospective Cohort Study.
    Arch Bronconeumol. 2024;60:652-655.
    PubMed    
    
    
    
70. PINERO-GUTIERREZ P, Villar-Alvarez F, Asensio-Mathews P, Gonzalez-Peinado D, et al
    Organizing Pneumonia Secondary to ASIA Syndrome.
    Arch Bronconeumol. 2024;60:658-659.
    PubMed    
    
    
    
71. JO YS, Rhee CK, Kim SH, Lee H, et al
    Spirometric Transition of at Risk Individuals and Risks for Progression to Chronic Obstructive Pulmonary Disease in General Population.
    Arch Bronconeumol. 2024;60:634-642.
    PubMed     Abstract available
    
    
    
72. KERGET B, Cinar I, Akdag BN, Yesilyurt M, et al
    New Indicators of Exercise Capacity and Respiratory Function in COPD Patients: The Role of Gastrocnemius Muscle Oxygenation and Elastography Levels.
    Arch Bronconeumol. 2024;60:643-645.
    PubMed    
    
    
    
73. KHO SS, Ing SK, Tie ST
    The Effect of Bronchoscopic Lung Volume Reduction on Hemidiaphragm Excursion.
    Arch Bronconeumol. 2024;60:668-669.
    PubMed    
    
    
    September 2024
74. PLAZA V, Garcia G, Perez de Llano L, Quirce S, et al
    Initiating Biological Treatment of Asthma: When is the Right Time?
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00364.
    PubMed    
    
    
    
75. TIOTIU CEPUC A, Steiropoulos P, Novakova S, Nedeva D, et al
    Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions.
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00367.
    PubMed     Abstract available
    
    
    
76. TRAVERSI L, Garriga-Grimau L, Moreno-Galdo A, Polverino E, et al
    The In-between: Time to Talk About Bronchiectasis in Adolescents and Their Transition to Adult Care.
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00359.
    PubMed     Abstract available
    
    
    
77. BARREIRO E, Gea J
    Muscle Fatigability of Patients With Severe COPD and Chronic Respiratory Failure: The Contribution of Respiratory Factors.
    Arch Bronconeumol. 2024;60:543-544.
    PubMed    
    
    
    
78. MALLAH N, Urbieta AD, Rivero-Calle I, Gonzalez-Barcala FJ, et al
    New Vaccines for Chronic Respiratory Patients.
    Arch Bronconeumol. 2024;60:565-575.
    PubMed     Abstract available
    
    
    
79. VILLENEUVE T, Guilleminault L, Guibert N
    Sequential and Multimodal Bronchoscopic Interventions for COPD: Toward a Highly Personalized Interventional Pulmonology?
    Arch Bronconeumol. 2024;60:600-601.
    PubMed    
    
    
    August 2024
80. ALOBID I, Bernal-Sprekelsen M, Mullol J
    The Importance of Multidisciplinary Teams in the Evaluation of the Remission of Chronic Rhinosinusitis in Severe Asthma.
    Arch Bronconeumol. 2024 Aug 31:S0300-2896(24)00317.
    PubMed    
    
    
    
81. JACOME C, Jacome M, Correia S, Flores I, et al
    Effectiveness, Adherence and Safety of Home High Flow Nasal Cannula in Chronic Respiratory Disease and Respiratory Insufficiency: A Systematic Review.
    Arch Bronconeumol. 2024;60:490-502.
    PubMed     Abstract available
    
    
    July 2024
82. GIL-MARTINEZ M, Rodrigo-Munoz JM, Antonio Canas J, Sastre J, et al
    Sputum Proteome Reveals Differences Between Eosinophilic and Non-eosinophilic Asthma Phenotypes.
    Arch Bronconeumol. 2024 Jul 20:S0300-2896(24)00273.
    PubMed    
    
    
    
83. WU X, Deng Z, Wu F, Zheng Y, et al
    Clinical Characteristics and 2-Year Outcomes of Chronic Obstructive Pulmonary Disease Patients With High Blood Eosinophil Counts: A Population-based Prospective Cohort Study in China.
    Arch Bronconeumol. 2024;60:402-409.
    PubMed     Abstract available
    
    
    
84. AGUSTI A, Lopez-Campos JL, Miravitlles M, Soler-Cataluna JJ, et al
    Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial.
    Arch Bronconeumol. 2024;60:417-422.
    PubMed     Abstract available
    
    
    
85. PANERONI M, Cavicchia A, Beatrice S, Bertacchini L, et al
    The Influence of Lung Function and Respiratory Muscle Strength on Quadriceps Muscle Fatigability in COPD Patients Under Long-term Oxygen Therapy.
    Arch Bronconeumol. 2024;60:410-416.
    PubMed     Abstract available
    
    
    June 2024
86. COSIO BG, Shafiek H, Torrego A
    Bronchoscopy in Severe Asthmatics: Is it a Safe Procedure?
    Arch Bronconeumol. 2024 Jun 18:S0300-2896(24)00224.
    PubMed    
    
    
    
87. MA D, Munoz X, Ojanguren I, Romero-Mesones C, et al
    Increased TGFbeta1, VEGF and IFN-gamma in the Sputum of Severe Asthma Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Jun 7:S0300-2896(24)00221.
    PubMed     Abstract available
    
    
    
88. DE MIGUEL-DIEZ J, Gomez Doblas JJ
    Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Response to Additional Considerations.
    Arch Bronconeumol. 2024;60:392-393.
    PubMed    
    
    
    
89. GOLPE R, Figueira-Goncalves JM
    Comment on "Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease".
    Arch Bronconeumol. 2024;60:391.
    PubMed    
    
    
    
90. FERNANDEZ-VILLAR A, Cimas Hernando JE, Figueira Goncalves JM, De Miguel Diez J, et al
    Continuity of Care in Chronic Obstructive Pulmonary Disease Exacerbations: Challenges and Priorities.
    Arch Bronconeumol. 2024;60:327-329.
    PubMed    
    
    
    May 2024
91. GONZALEZ J, Seijo LM, de-Torres JP, Benitez ID, et al
    Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP.
    Arch Bronconeumol. 2024 May 16:S0300-2896(24)00170.
    PubMed     Abstract available
    
    
    
92. GARRIGA-GRIMAU L, Sanz-Santiago V, Moreno-Galdo A
    Implementation of the Spanish Paediatric Bronchiectasis Registry (Child-BEAR-es Registry).
    Arch Bronconeumol. 2024 May 6:S0300-2896(24)00143.
    PubMed    
    
    
    
93. FORCADA BARREDA C, Fuentes Gago MG, Gomez Hernandez MT
    Subconjunctival Emphysema After Videothoracoscopic Segmentectomy.
    Arch Bronconeumol. 2024 May 4:S0300-2896(24)00138.
    PubMed    
    
    
    
94. BALLESTEROS-REVIRIEGO G, Arbillaga-Etxarri A, Marti JD
    Inspiratory Muscle Training: Back to Basics Must be the First Step?
    Arch Bronconeumol. 2024;60:267-268.
    PubMed    
    
    
    
95. PAPI A, Alfano F, Bigoni T, Mancini L, et al
    N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
    Arch Bronconeumol. 2024;60:269-278.
    PubMed     Abstract available
    
    
    
96. CUENCA PERIS S, Martinez Tomas R, Briones Gomez A, Cases Viedma E, et al
    What to Do When Endobronchial Volume Reduction Treatment Fails.
    Arch Bronconeumol. 2024;60:319-320.
    PubMed    
    
    
    April 2024
97. CAKIR E, Ibis E, Yuzuak E
    Probable Invasive Aspergillosis Causing Massive Subcutaneous Emphysema by Rupturing the Pleura and Forming a Bronchopleural Fistula.
    Arch Bronconeumol. 2024 Apr 30:S0300-2896(24)00131.
    PubMed    
    
    
    
98. MASELLI DJ, Diaz AA
    Mortality Risk in Bronchiectasis.
    Arch Bronconeumol. 2024 Apr 24:S0300-2896(24)00114.
    PubMed    
    
    
    
99. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G, Blanco-Aparicio M, et al
    Spanish Consensus on Remission in Asthma (REMAS).
    Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00109.
    PubMed     Abstract available
    
    
    
100. PAN CX, He ZF, Lin SZ, Yue JQ, et al
     Clinical Characteristics and Outcomes of the Phenotypes of COPD-Bronchiectasis Association.
     Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00110.
     PubMed     Abstract available
     
     
     
101. MAKRINIOTI H, Zhu Z, Saglani S, Camargo CA, et al
     Infant Bronchiolitis Endotypes and the Risk of Developing Childhood Asthma: Lessons From Cohort Studies.
     Arch Bronconeumol. 2024;60:215-225.
     PubMed     Abstract available
     
     
     
102. DE MIGUEL-DIEZ J, Nunez Villota J, Santos Perez S, Manito Lorite N, et al
     Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.
     Arch Bronconeumol. 2024;60:226-237.
     PubMed     Abstract available
     
     
     March 2024
103. GAO YH, Zhu YN, Bai JW, Liang S, et al
     Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.
     Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00073.
     PubMed    
     
     
     
104. CHANG AB, Dharmage SC, Marchant JM, McCallum GB, et al
     Improving the Diagnosis and Treatment of Paediatric Bronchiectasis Through Research and Translation.
     Arch Bronconeumol. 2024 Mar 10:S0300-2896(24)00062.
     PubMed     Abstract available
     
     
     
105. URRUTIA-ROYO B, Garcia-Olive I, Compte M, Folgado C, et al
     Effect of Comorbidities and Gender Differences in Survival in Patients With Bronchiectasis.
     Arch Bronconeumol. 2024 Mar 2:S0300-2896(24)00055.
     PubMed    
     
     
     
106. VITACCA M, Malovini A, Paneroni M, Spanevello A, et al
     Predicting Response to In-Hospital Pulmonary Rehabilitation in Individuals Recovering From Exacerbations of Chronic Obstructive Pulmonary Disease.
     Arch Bronconeumol. 2024;60:153-160.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum